Literature DB >> 11976996

Assessment of readiness to initiate antiretroviral therapy.

Tanya T Morgenstern1, Deanna E Grimes, Richard M Grimes.   

Abstract

PURPOSE: An important factor in adherence to antiretroviral therapy (ART) is the patient's commitment to follow the regimen, which suggests that therapy should be initiated only when the patient is ready to make such a commitment. Because there has been no research on patient readiness for ART, this study was undertaken to investigate factors that influence the decision of an HIV-positive person to seek medical care and to initiate ART.
METHOD: The investigators surveyed 83 HIV-infected patients on ART. Participants completed a questionnaire that obtained information on the length of time from when they learned of their HIV-positive status to when they sought medical care, the length of time from when they learned of their HIV-positive status to when they were ready to initiate therapy, and psychological and social factors thought to be associated with readiness.
RESULTS: Respondents had a mean age of 37 years, 71% were male, and 65% were African American. Only 42% said they sought medical care immediately upon learning their HIV diagnosis. Fifty percent were ready to initiate therapy immediately upon learning their diagnosis, and 25% were ready within 1 year. Sixty-four percent of respondents experienced barriers that interfered with therapy initiation. Although 98% of respondents experienced at least one emotional response to HIV diagnosis, less than 25% of respondents thought that their responses interfered with readiness. However, five emotional responses demonstrated an association with readiness through chi-square analysis.
CONCLUSION: Further research is needed to explain the relationships among emotional responses to HIV diagnosis, readiness to initiate ART, and adherence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976996     DOI: 10.1310/T6Y6-BRCW-AR7A-WVA3

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  8 in total

Review 1.  The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Authors:  Thomas P Giordano; Maria E Suarez-Almazor; Richard M Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

2.  Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape.

Authors:  Jan Fehr; Dunja Nicca; Jean-Christophe Goffard; David Haerry; Michael Schlag; Vasileios Papastamopoulos; Andy Hoepelman; Athanasius Skoutelis; Ruth Diazaraque; Bruno Ledergerber
Journal:  Infection       Date:  2016-03-16       Impact factor: 3.553

3.  Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings.

Authors:  M Isabel Fernández; Sybil Hosek; Jacob C Warren; Robin J Jacobs; Nilda Hernandez; Jaime Martinez
Journal:  AIDS Care       Date:  2011-06-21

Review 4.  Readiness: the state of the science (or the lack thereof).

Authors:  Richard M Grimes; Deanna E Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

5.  Examining Correlates of Pre-ART and Early ART Adherence to Identify Key Factors Influencing Adherence Readiness.

Authors:  Kyle Gordon; Risa M Hoffman; Gulrez Azhar; Daniel Ramirez; Stefan Schneider; Glenn J Wagner
Journal:  AIDS Behav       Date:  2021-01

6.  Readiness in HIV Treatment Adherence: A Matter of Confidence. An Exploratory Study.

Authors:  Helene Sylvain; Philippe Delmas
Journal:  Open AIDS J       Date:  2011-12-29

7.  The Role of Financial Incentives Along the Antiretroviral Therapy Adherence Continuum: A Qualitative Sub-study of the HPTN 065 (TLC-Plus) Study.

Authors:  Elizabeth E Tolley; Jamilah Taylor; Allison Pack; Elizabeth Greene; Jill Stanton; Victoria Shelus; Richard Dunner; Theo Hodge; Bernard Branson; Wafaa M El-Sadr; Theresa Gamble
Journal:  AIDS Behav       Date:  2018-01

8.  Factors associated with readiness to start antiretroviral therapy (ART) among young people (15-24 years) at four HIV clinics in Mulago Hospital, Uganda.

Authors:  Jonathan Nkalubo; Moureen Mugaba; Ignatius Asasira; Racheal Nakiganda; Florence Namutebi; Nick Ntore Arnaud; Nicholas Kagumba Musisi; Trinity Abasira; Pius Jemba; Racheal Ndyabawe; Rosette Tumuhairwe; Charles Batte; Sabrina Bakeera-Kitaka
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 0.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.